Solid Biosciences Inc.SLDBNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank50
5Y CAGR-20.3%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-20.3%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1.26M-48.7%
2024$2.46M-4.9%
2023$2.58M-
2022$0.00-
2021$0.00-100.0%
2020$3.92M+38.9%
2019$2.82M+80.3%
2018$1.57M-
2017$0.00-100.0%
2016$56000.00-